Modified αVIII-FLI Assay for Anti-FVIII Antibodies
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Centers for Disease Control and Prevention, Emory University, Bleeding & Clotting Disorders Institute, National Hemophilia Foundation, Virginia Commonwealth University
Protocol cited in 5 other protocols
Variable analysis
- Plasma sample dilution (1:30 in PBS containing 1% dried milk)
- Median fluorescence intensity (MFI) of anti-FVIII antibodies
- Incubation of plasma samples with SeroMAP beads coupled to Kogenate FS
- Incubation with biotinylated anti-human Ig (anti-IgG1, anti-IgG2, anti-IgG3, anti-IgG4, anti-IgM)
- Incubation with R-phycoerythrin-conjugated streptavidin
- Use of Bio-Plex 200 suspension array system
- Threshold for positivity set at two standard deviations above the mean MFI of healthy donors
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!